Stemness Related LncRNAs Signature for the Prognosis and Tumor Immune Microenvironment of CcRCC Patients

Overview

Journal BMC Med Genomics

Publisher Biomed Central

Specialty Genetics

Date 2024 Jun 1

PMID 38822402

Authors

Mengjiao Zhang

Jiqiang Zhang

Xuemei Liang

Ming Zhang

Affiliations

Soon will be listed here.

Abstract

Long non-coding RNAs (lncRNAs) and cancer stem cells (CSCs) are crucial for the growth, migration, recurrence, and medication resistance of tumors. However, the impact of lncRNAs related to stemness on the outcome and tumor immune microenvironment (TIME) in clear cell renal cell carcinoma (ccRCC) is still unclear. In this study, we aimed to predict the outcome and TIME of ccRCC by constructing a stem related lncRNAs (SRlncRNAs) signature. We firstly downloaded ccRCC patients' clinical data and RNA sequencing data from UCSC and TCGA databases, and abtained the differentially expressed lncRNAs highly correlated with stem index in ccRCC through gene expression differential analysis and Pearson correlation analysis. Then, we selected suitable SRlncRNAs for constructing a prognostic signature of ccRCC patients by LASSO Cox regression. Further, we used nomogram and Kaplan Meier curves to evaluate the SRlncRNA signature for the prognose in ccRCC. At last, we used ssGSEA and GSVA to evaluate the correlation between the SRlncRNAs signature and TIME in ccRCC. Finally, We obtained a signtaure based on six SRlncRNAs, which are correlated with TIME and can effectively predict the ccRCC patients' prognosis. The SRlncRNAs signature may be a noval prognostic indicator in ccRCC.

References

Markiewski M, Nilsson B, Nilsson Ekdahl K, Mollnes T, Lambris J . Complement and coagulation: strangers or partners in crime?. Trends Immunol. 2007; 28(4):184-92. DOI: 10.1016/j.it.2007.02.006. View

Arab A, Akbarian S, Ghiyasvand R, Miraghajani M . The effects of conjugated linoleic acids on breast cancer: A systematic review. Adv Biomed Res. 2016; 5:115. PMC: 4964663. DOI: 10.4103/2277-9175.185573. View

Amara U, Rittirsch D, Flierl M, Bruckner U, Klos A, Gebhard F . Interaction between the coagulation and complement system. Adv Exp Med Biol. 2008; 632:71-9. PMC: 2713875. DOI: 10.1007/978-0-387-78952-1_6. View

Nguyen L, Vanner R, Dirks P, Eaves C . Cancer stem cells: an evolving concept. Nat Rev Cancer. 2012; 12(2):133-43. DOI: 10.1038/nrc3184. View

Dong H, Strome S, Salomao D, Tamura H, Hirano F, Flies D . Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002; 8(8):793-800. DOI: 10.1038/nm730. View

Giraldo N, Becht E, Vano Y, Petitprez F, Lacroix L, Validire P . Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma. Clin Cancer Res. 2017; 23(15):4416-4428. DOI: 10.1158/1078-0432.CCR-16-2848. View

Ribas A, Wolchok J . Cancer immunotherapy using checkpoint blockade. Science. 2018; 359(6382):1350-1355. PMC: 7391259. DOI: 10.1126/science.aar4060. View

Brooks M, Burness M, Wicha M . Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer. Cell Stem Cell. 2015; 17(3):260-71. PMC: 4560840. DOI: 10.1016/j.stem.2015.08.014. View

Jiao X, Katiyar S, Willmarth N, Liu M, Ma X, Flomenberg N . c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion. J Biol Chem. 2010; 285(11):8218-26. PMC: 2832973. DOI: 10.1074/jbc.M110.100792. View

10.

Chen Y, Hu W, Wei X, Zhang L, Shao Y, Tian J . Development and validation of a novel 5 cuproptosis-related long noncoding RNA signature to predict diagnosis, prognosis, and drug therapy in clear cell renal cell carcinoma. Transl Androl Urol. 2023; 12(4):622-641. PMC: 10170269. DOI: 10.21037/tau-23-65. View

11.

Xin Y, Bian B, Yang X, Cui W, Cui H, Cui Y . POU5F1 enhances the invasiveness of cancer stem-like cells in lung adenocarcinoma by upregulation of MMP-2 expression. PLoS One. 2014; 8(12):e83373. PMC: 3875455. DOI: 10.1371/journal.pone.0083373. View

12.

Wang P, Wu S, Zeng X, Zhang Y, Zhou Y, Su L . BCAT1 promotes proliferation of endometrial cancer cells through reprogrammed BCAA metabolism. Int J Clin Exp Pathol. 2020; 11(12):5536-5546. PMC: 6963089. View

13.

Eckl J, Buchner A, Prinz P, Riesenberg R, Siegert S, Kammerer R . Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging. J Mol Med (Berl). 2011; 90(1):55-66. DOI: 10.1007/s00109-011-0806-7. View

14.

Leonard W, Lin J . Cytokine receptor signaling pathways. J Allergy Clin Immunol. 2000; 105(5):877-88. DOI: 10.1067/mai.2000.106899. View

15.

Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z . clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021; 2(3):100141. PMC: 8454663. DOI: 10.1016/j.xinn.2021.100141. View

16.

Tamma R, Rutigliano M, Lucarelli G, Annese T, Ruggieri S, Cascardi E . Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment. Urol Oncol. 2019; 37(6):355.e11-355.e19. DOI: 10.1016/j.urolonc.2019.01.025. View

17.

Gaffen S, Liu K . Overview of interleukin-2 function, production and clinical applications. Cytokine. 2004; 28(3):109-23. DOI: 10.1016/j.cyto.2004.06.010. View

18.

Liu S, Wang Z, Zhu R, Wang F, Cheng Y, Liu Y . Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2. J Vis Exp. 2021; (175). DOI: 10.3791/62528. View

19.

Wang X, Liu Y, Long F, Liu L, Fan C . Identification of a lncRNA prognostic signature-related to stem cell index and its significance in colorectal cancer. Future Oncol. 2021; 17(23):3087-3100. DOI: 10.2217/fon-2020-1163. View

20.

den Hartigh L . Conjugated Linoleic Acid Effects on Cancer, Obesity, and Atherosclerosis: A Review of Pre-Clinical and Human Trials with Current Perspectives. Nutrients. 2019; 11(2). PMC: 6413010. DOI: 10.3390/nu11020370. View